Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04348123 · ClinicalTrials.gov registry record · NA

Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography

A NA study of Breast Cancer, sponsored by Case Comprehensive Cancer Center.

Active
Registry status
NA
Development phase
203
Enrollment target
1
Study location

NCT04348123 is a NA study of Breast Cancer that is active but no longer recruiting, run by Case Comprehensive Cancer Center. The registered enrollment target is 203 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04348123, a NA study of Breast Cancer, is active but no longer recruiting, sponsored by Case Comprehensive Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
203 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to identify interventions that are designed to better serve women who are homeless, with a specific focus on increasing screening rates and decreasing late stage breast cancer diagnosis among this high-risk understudied community of women. As a result, the study team hopes to influence the broader homeless healthcare initiative

Conditions Studied

Interventions

  • OTHER Survey
  • BEHAVIORAL Education Session

Study Locations (1)

Ohio

  • Cleveland Clinic, Case Comprehensive Cancer Center - Cleveland

Trial Details

FieldValue
Enrollment Target 203 participants
Start Date 2022-03-15
Est. Completion 2025-11
Phase NA

Sponsor

Case Comprehensive Cancer Center

407 total trials

What the Registry Record Tells You About NCT04348123

The ClinicalTrials.gov registry entry for NCT04348123 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Survey is the first listed.

NCT04348123 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04348123 about?

NCT04348123 is a clinical study titled "Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography". The purpose of this study is to identify interventions that are designed to better serve women who are homeless, with a specific focus on increasing screening rates and decreasing late stage breast cancer diagnosis among this high-risk understudied community of women. As a result, the study team hope...

What is the current status of trial NCT04348123?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 203 participants. The study started on 2022-03-15. Estimated completion is 2025-11.

What conditions does trial NCT04348123 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT04348123?

The interventions under investigation include: Survey (OTHER), Education Session (BEHAVIORAL).

Who is sponsoring clinical trial NCT04348123?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04348123 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.